Immune System Diseases: all 288 studies

Page 2 of 3. Open to participants first (80), then studies with results posted, then the rest; newest registration first within each.

• Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring SubjectsCompletedNCT03627767Phase 3Results posted
• Effect of Benralizumab in Atopic DermatitisCompletedNCT03563066Phase 2Results posted
• Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With OcrevusCompletedNCT03562975Results posted
• DPX-Survivac and Checkpoint Inhibitor in DLBCLCompletedNCT03349450Phase 2Results posted
• Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 DiabetesCompletedNCT03345004Phase 2Results posted
• Mechanism of Action of Ocrelizumab in Multiple SclerosisCompletedNCT03344094Results posted
• Exercise Snacks and Glutamine to Improve Glucose Control in Adolescents With Type 1 DiabetesCompletedNCT03199638Not applicableResults posted
• Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic DermatitisCompletedNCT03054428Phase 3Results posted
• Women Empowered to Live With Lupus StudyCompletedNCT02988661Not applicableResults posted
• Treatment of Chronic Graft Versus Host Disease With Arsenic TrioxideCompletedNCT02966301Phase 2Results posted
• Administration of T Lymphocytes for Prevention of Relapse of LymphomasActive, not recruitingNCT02663297Phase 1Results posted
• Determination of the Sensitivity and Specificity of Prick Test Betula VerrucosaCompletedNCT02527187Phase 2Results posted
• The Effect of Different Volumes of Physical Exercise on the Immune SystemCompletedNCT02331446Not applicableResults posted
• Asthma Data Innovation Demonstration ProjectCompletedNCT02162576Not applicableResults posted
• A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)CompletedNCT01918033Phase 3Results posted
• Anakinra for Behcet s DiseaseCompletedNCT01441076Phase 1/2Results posted
• Zoster Vaccine Response in the Frail ElderlyCompletedNCT01328548Results posted
• Mesalamine to Reduce T Cell Activation in HIV InfectionCompletedNCT01090102Phase 4Results posted
• Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)CompletedNCT01002742Phase 3Results posted
• Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302)CompletedNCT00224874Phase 2Results posted
• T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic DisordersTerminatedNCT00176826Phase 2/3Results posted
• A Clinical Trial for Evaluation of Efficacy, Safety and Immunogenicity of GNR-127 (Recombinant ABP Antigen Protein Which Carries a Birch Pollen Allergen [BET V 1] and an Apple Allergen [MAL D 1]) in Patients With Birch Pollen Allergic Rhinitis.CompletedNCT07155499Phase 1/2
• Hemogram Parameter Changes With Sepsis FilterCompletedNCT06948630
• A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren'sActive, not recruitingNCT06928142Phase 2
• Gut Dysbiosis in Spinal Cord Injury RehabilitationCompletedNCT06892106
• Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)Active, not recruitingNCT06843239Phase 2
• PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPFCompletedNCT06683612Phase 1
• IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple SclerosisSuspendedNCT06677710Phase 1
• A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic AsthmaTerminatedNCT06592768Phase 1
• A Study of Genolair in Two Dosage Forms (Solution and Lyophilisate) and Xolair® in Healthy VolunteersCompletedNCT06494345Phase 1
• A Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment With H1- AntihistaminesTerminatedNCT06353971Phase 1/2
• Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)CompletedNCT06353087
• Biodiversity Interventions for Well-BeingActive, not recruitingNCT06353035Not applicable
• The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)WithdrawnNCT06291415Phase 1
• Study of Cannabidiol (CBD) in Healthy VolunteersCompletedNCT06286839Not applicable
• Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU)CompletedNCT06162728Phase 1/2
• COVID-19 Post-Vaccination ObservationActive, not recruitingNCT06107348
• Study on the Effects of Wheat and Corn Germ Blend Oil on Antioxidation and Immune Regulation of Dyslipidemia PopulationCompletedNCT06060509Not applicable
• Exploring Outcomes and Characteristics of Myasthenia Gravis 2CompletedNCT06002945
• HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD ProphylaxisActive, not recruitingNCT06001385Phase 2
• Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus ErythematosusActive, not recruitingNCT05966480Phase 2
• Project Khanya: Peer-Delivered Intervention to Improve HIV Medication Adherence and Substance Use in South AfricaActive, not recruitingNCT05933226Not applicable
• A Study of Safety and Drug Levels of HIB210 in Healthy VolunteersCompletedNCT05928585Phase 1
• Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)Active, not recruitingNCT05925803Phase 3
• A Study to Determine the Effect of Multiple Oral Doses of SLx-2119 in Healthy Male SubjectsCompletedNCT05918627Phase 1
• A Study to Determine the Effect of 500 mg Oral Dose of KD025 in Healthy Male and Post-menopausal Female SubjectsCompletedNCT05918614Phase 1
• A Study to Determine the Effect of Multiple Oral Doses and Regimens of KD025 in Healthy Male and Post-menopausal Female SubjectsCompletedNCT05918588Phase 1
• The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia GravisCompletedNCT05917184
• Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult CareActive, not recruitingNCT05910840Not applicable
• Compassionate Use of Dupilumab for Adult Patients With Bullous PemphigoidApproved for marketingNCT05906706
• A Study to Assess the Effect of Oral Belumosudil on Inhibition of Various Proteins in the Fed State in Healthy Male SubjectsCompletedNCT05806567Phase 1
• Genetic and Immunologic Characterization of IEICompletedNCT05803356
• A Study of Telitacicept for IgA Nephropathy (TELIGAN)Active, not recruitingNCT05799287Phase 3
• Ukulele Playing to Improve Cognition in People with Multiple Sclerosis: a Feasibility StudyCompletedNCT05792176Not applicable
• Study to Evaluate the Safety and Feasibility of Diamyd® in Individuals at Risk for Type 1 DiabetesActive, not recruitingNCT05683990Phase 2
• A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus ErythematosusActive, not recruitingNCT05672576Phase 3
• Effect of Stellate Ganglion Block on ME/CFSCompletedNCT05664711Phase 1
• Impact of Seasonal Malaria Chemoprevention on Immunity Against Malaria Among Children in Northern BeninCompletedNCT05650502
• A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus ErythematosusActive, not recruitingNCT05648500Phase 3
• 24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3)CompletedNCT05634746Phase 3
• A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut AllergyActive, not recruitingNCT05621317Phase 2
• A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus ErythematosusActive, not recruitingNCT05620407Phase 3
• A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)Active, not recruitingNCT05617677Phase 3
• Next-generation Effects of Vitamin D Supplementation in PregnancyStatus unknownNCT05616117
• Telerehabilitation of Multidomain Cognitive Impairment in Multiple SclerosisTerminatedNCT05611047Not applicable
• Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus ErythematosusTerminatedNCT05591222Phase 2
• An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1DTerminatedNCT05565248Phase 1
• Nutraceuticals and Functional FoodsStatus unknownNCT05509075
• Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia GravisCompletedNCT05451212Phase 1
• Group Education Trial to Improve Transition for Parents of Adolescents With T1DCompletedNCT05445284Not applicable
• A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell LymphomaWithdrawnNCT05431179Phase 3
• Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen DeterminationStatus unknownNCT05414890
• Phenotyping Mitochondrial and Immune Dysfunction in POTS With Targeted Clinical Intervention.Active, not recruitingNCT05409651Not applicable
• Electro-acupuncture at Zusanli, Qihai, and Guanyuan Acupoints Regulate Immune Function in Patients With SepsisCompletedNCT05367986Not applicable
• Immune Diversity Response to Oral Dosing of Nutritional Health Products in Healthy ParticipantsCompletedNCT05242718Not applicable
• The Impact of a Polyphenol-Rich Supplement on Epigenetic and Cellular Markers of Immune AgeCompletedNCT05234203Not applicable
• Transcriptomics of Mononuclear Cells and Inflammatory Status of Obese Patients Treated With Omega-3 Fatty AcidsWithdrawnNCT05219890Not applicable
• An Open-Label, FIH Study Evaluating the Safety and Tolerability of VCTX210A Combination Product in Subjects With T1DCompletedNCT05210530Phase 1
• (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic MastocytosisActive, not recruitingNCT05186753Phase 2
• Early Onset Preeclampsia and Nectin-4CompletedNCT05098691
• Expanded Access Protocol for Patients With Eosinophilic EsophagitisNo longer availableNCT05095116
• A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 DiabetesTerminatedNCT05018585Phase 3
• Co-Sér: Serological Analysis and Viral Neutralization in People With a Documented COVID-19 InfectionCompletedNCT05000307Not applicable
• Research on the Application and Mechanism of New Biological Probes in BiomedicineCompletedNCT04977739
• Fighting Immunosenescence and Promoting Immunity by a Fasting-mimicking Diet Elderly.Status unknownNCT04928963Phase 1/2
• HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation CyclophosphamideActive, not recruitingNCT04904588Phase 2
• A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)Active, not recruitingNCT04895696Phase 2
• Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or NatalizumabCompletedNCT04837651
• Covid-19 Vaccine Responsiveness in MM and WaldenstromCompletedNCT04830046
• COVID-19, Aging, and Cardiometabolic Risk Factors StudyStatus unknownNCT04802044
• Immuno-Oncology Database and BioregistryCompletedNCT04656873
• Relationship of Endoplasmic Reticulum Stress and Tonsillar Tissue DiseasesCompletedNCT04653376
• Cold Water Immersion and Atherosclerosis, Inflammation, Fat Accumulation and Lipid Profile ParametersSuspendedNCT04642066Not applicable
• GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALLTerminatedNCT04601584Phase 1/2
• Is Lymphocyte Subtype Important for Acute Pancreatitis Severity?CompletedNCT04502940
• Home-based Aerobic Training Among Adolescents With Chronic Diseases During COVID-19 PandemicStatus unknownNCT04458246Not applicable
• A Study of Subcutaneous KY1005 in Healthy VolunteersCompletedNCT04449939Phase 1
• Pediatrics HOT COVID-19 Database in NY TristateCompletedNCT04445402
• PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected CohortCompletedNCT04444609
• Immune Changes in Severe COVID-19 Pulmonary InfectionsCompletedNCT04386395

← Immune System Diseases overview